Alan List
CIK 1858530 · View on SEC EDGAR ↗
First SEC filing: Oct. 22, 2024 · Latest: Oct. 22, 2024
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | DTIL | S 10b5-1 | 290 | $10.32 | $2,993 | 4,488 Direct | -6.07% | Disposed | -16.3% (price as of 2026-08-19) |
| April 30, 2024 | DTIL | S 10b5-1 | 238 | $10.03 | $2,387 | 3,796 Direct | -5.90% | Disposed | -13.9% (price as of 2026-08-19) |
| Jan. 22, 2024 | DTIL | S 10b5-1 | 21,526 | $0.36 | $7,749 | 94,982 Direct | -18.48% | Disposed | -20.0% (price as of 2026-08-19) |
| April 27, 2023 | DTIL | S 10b5-1 | 7,771 | $0.79 | $6,139 | 56,496 Direct | -12.09% | Disposed | -63.6% (price as of 2026-08-19) |
| March 6, 2023 | DTIL | S 10b5-1 | 9,473 | $1.07 | $10,136 | 38,240 Direct | -19.85% | Disposed | -73.1% (price as of 2026-08-19) |
| April 27, 2022 | DTIL | S 10b5-1 | 7,775 | $2.10 | $16,328 | 18,260 Direct | -29.86% | Disposed | -86.3% (price as of 2026-08-19) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | HURA | Options (Right to Buy) | Common Stock (156,240) | $1.29 | Feb. 12, 2036 | 156,240 | Acquired |
| Jan. 2, 2025 | HURA | Options (Right to Buy) | Common Stock (51,275) | $4.11 | Jan. 2, 2035 | 51,275 | Acquired |
| Oct. 18, 2024 | HURA | Options (Right to Buy) | Common Stock (13,553) | $4.14 | Feb. 28, 2034 | 13,553 | Acquired |
| Oct. 18, 2024 | HURA | Options (Right to Buy) | Common Stock (13,553) | $3.69 | Jan. 16, 2033 | 13,553 | Acquired |
| May 1, 2024 | DTIL | Restricted Stock Units | Common Stock (982) | — | — | 982 | Disposed |
| April 26, 2024 | DTIL | Restricted Stock Units | Common Stock (868) | — | — | 868 | Disposed |
| Jan. 20, 2024 | DTIL | Restricted Stock Units | Common Stock (60,012) | — | — | 60,012 | Disposed |
| April 26, 2023 | DTIL | Restricted Stock Units | Common Stock (26,027) | — | — | 26,027 | Disposed |
| March 3, 2023 | DTIL | Restricted Stock Units | Common Stock (29,453) | — | — | 29,453 | Acquired |
| Jan. 20, 2023 | DTIL | Restricted Stock Units | Common Stock (180,000) | — | — | 180,000 | Acquired |
| April 26, 2022 | DTIL | Restricted Stock Units | Common Stock (26,035) | — | — | 26,035 | Disposed |
| March 3, 2022 | DTIL | Restricted Stock Units | Common Stock (88,343) | — | — | 88,343 | Acquired |
| March 3, 2022 | DTIL | Employee Stock Option (Right to Buy) | Common Stock (140,299) | $4.08 | March 2, 2032 | 140,299 | Acquired |
| June 7, 2021 | DTIL | Restricted Stock Units | Common Stock (78,090) | — | — | 78,090 | Acquired |
| June 7, 2021 | DTIL | Employee Stock Option (Right to Buy) | Common Stock (134,186) | $11.34 | June 6, 2031 | 134,186 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
DTIL
M.D. Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $475,721 | $191,200 | $217,800 | $0 | — | — | $25,250 | $909,970 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.